Literature DB >> 97197

Pituitary responsiveness to thyrotropin releasing hormone in insulin-dependent diabetes mellitus.

J E Morley, C Klein, W J Kalk, B I Joffe, D Saffer, L A Distiller, H C Seftel.   

Abstract

The pituitary responses to the intravenous administration of 200 mg of Thyrotropin Releasing Hormone were investigated in 14 poorly controlled insulin dependent diabetic males and in nine matched controls. The mean TSH and prolactin responses in the two groups were similar although both tended to be lower in the diabetics. There was a small FSH rise in 11 of the 23 subjects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97197     DOI: 10.1055/s-0028-1093441

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

1.  Impaired thyrotrophin secretion following the administration of thyrotrophin-releasing hormone in type II diabetes mellitus.

Authors:  M Small; H N Cohen; J A MacLean; G H Beastall; A C MacCuish
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

Review 2.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

3.  The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.

Authors:  C Shigemasa; K Abe; S Taniguchi; Y Mitani; Y Ueta; T Adachi; K Urabe; T Tanaka; A Yoshida; T Hori
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

4.  Hyperprolactinaemia in male diabetics.

Authors:  A D Mooradian; J E Morley; C J Billington; M F Slag; M K Elson; R B Shafer
Journal:  Postgrad Med J       Date:  1985-01       Impact factor: 2.401

Review 5.  Endobiogeny: a global approach to systems biology (part 1 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat
Journal:  Glob Adv Health Med       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.